help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cittadini, A.
Right arrow Articles by Douglas, P. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cittadini, A.
Right arrow Articles by Douglas, P. S.
Endocrinology Vol. 138, No. 12 5161-5169
Copyright © 1997 by The Endocrine Society

ARTICLES

Consequences of Growth Hormone Deficiency on Cardiac Structure, Function, and ß-Adrenergic Pathway: Studies in Mutant Dwarf Rats1

Antonio Cittadini, Hinrik Strömer, Dorothy E. Vatner, Jessica D. Grossman, Sarah E. Katz, Ross Clark, James P. Morgan and Pamela S. Douglas

Charles A. Dana Research Institute and the Harvard-Thorndike Laboratory, Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School (A.C., H.S., J.D.G., S.E.K., J.P.M., P.S.D.), Boston, Massachusetts 02215; New England Regional Primate Research Center (D.E.V.), Southborough, Massachusetts 01772; and Genentech (R.C.), South San Francisco, California 94080

Address all correspondence and requests for reprints to: Pamela S. Douglas, M.D., Cardiovascular Division, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, Massachusetts 02215. E-mail: pdouglas{at}bidmc.harvard.edu

To evaluate GH’s role in cardiac physiology and its interrelationship with the ß-adrenergic system, we studied GH-deficient dwarf (dw/dw) and control rats in 4 groups of 20 each: dwarf group receiving placebo, dwarf-GH group receiving 2 mg/kg GH, dwarf-GH-propranolol group receiving 2 mg/kg GH and 750 mg/liter propranolol, and a control group of Lewis rats receiving placebo. Dwarf rats showed reduced left ventricular weight and myocyte cross-sectional area, and impaired cardiac performance in vitro. Left ventricular pressure-volume curves showed a shift upward and leftward, indicating reduced distensibility. These abnormalities reversed after GH treatment regardless of concomitant propranolol administration. Although isoproterenolol responsiveness was reduced in dwarf rats, there were no differences in ß-adrenergic receptor density, affinity, Na+,K+-adenosine triphosphatase activity, or adenylyl cyclase activity.

In summary, myocyte size, cardiac structure, myocardial contractility, and distensibility are abnormal in GH deficiency. The effects of GH are not mediated by the ß-adrenergic pathway, which, in turn, is unaffected by changes in the GH-insulin-like growth factor I axis. Thus, GH plays a regulatory role in normal cardiac physiology that is independent of the ß-adrenergic system.




This article has been cited by other articles:


Home page
 Eur J OrthodHome page
G. C. Bills, P. H. Buschang, R. Ceen, and R. J. Hinton
Timing effects of growth hormone supplementation on rat craniofacial growth
Eur J Orthod, April 1, 2008; 30(2): 153 - 162.
[Abstract] [Full Text] [PDF]

Home page
 Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
A. K. Reddy, D. Amador-Noguez, G. J. Darlington, B. A. Scholz, L. H. Michael, C. J. Hartley, M. L. Entman, and G. E. Taffet
Cardiac Function in Young and Old Little Mice
J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2007; 62(12): 1319 - 1325.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
D. I. Shulman, A. W. Root, F. B. Diamond, B. B. Bercu, R. Martinez, and R. J. Boucek Jr.
Effects of One Year of Recombinant Human Growth Hormone (GH) Therapy on Cardiac Mass and Function in Children with Classical GH Deficiency
J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4095 - 4099.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S. Marleau, N. Lapointe, J. Massicotte, C. Cemeus, G. Jasmin, L. Dumont, M. G. Sirois, J.-L. Rouleau, P. du Souich, and H. Ong
Effect of Chronic Treatment with Bovine Recombinant Growth Hormone on Cardiac Dysfunction and Lesion Progression in UM-X7.1 Cardiomyopathic Hamsters
Endocrinology, December 1, 2002; 143(12): 4846 - 4855.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
A. Cittadini, J. D. Grossman, H. Stromer, S. E. Katz, J. P. Morgan, and P. S. Douglas
Importance of an Intact Growth Hormone/Insulin-Like Growth Factor 1 Axis for Normal Post-Infarction Healing: Studies in Dwarf Rats
Endocrinology, January 1, 2001; 142(1): 332 - 338.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. Lu, G. Schwartzbauer, M. A. Sperling, S. U. Devaskar, S. Thamotharan, P. D. Robbins, C. F. McTiernan, J.-L. Liu, J. Jiang, S. J. Frank, et al.
Demonstration of Direct Effects of Growth Hormone on Neonatal Cardiomyocytes
J. Biol. Chem., June 15, 2001; 276(25): 22892 - 22900.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1997 by The Endocrine Society